The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash and cash equivalents at beginning of period | 73,278 | - |
| Net income | 39,228 | 30,102 |
| Depreciation and amortization | 15,362 | 29,919 |
| Deferred financing fees amortization | 73 | 171 |
| Amortization of operating lease rou asset | 3,253 | 5,972 |
| Impairment of long-lived assets | 0 | 3,427 |
| Bargain purchase loss/(gain) | -3,342 | - |
| Stock based compensation expense | 3,244 | 5,525 |
| Gain on sale of property, equipment and lease terminations | 40,850 | 487 |
| Deferred tax, net | 17,424 | 13,893 |
| Equity method earnings, net of dividends | 0 | 0 |
| Accounts receivable, net | 3,626 | -7,839 |
| Inventories | -5,999 | -14,464 |
| Prepaid expenses and other current assets | -8,485 | 5,795 |
| Other long-term assets | 624 | 1,112 |
| Accounts payable | -397 | -7,189 |
| Accrued expenses and other current liabilities | -7,637 | -12,298 |
| Other operating assets and liabilities, net | -5,098 | -5,869 |
| Net cash provided by operating activities | 48,374 | 90,300 |
| Payments on acquisitions, net of cash acquired | 500 | 80,669 |
| Capital expenditures | 11,852 | 14,353 |
| Proceeds from sale of property and equipment | 89,907 | 8,684 |
| Cash acquired in stock based business combination | 0 | - |
| Net cash provided by (used in) investing activities | 77,555 | -86,338 |
| Deferred debt issuance cost | 0 | 1,455 |
| Revolving credit facility borrowings | 8,000 | 136,200 |
| Revolving credit facility payments | 37,000 | 121,200 |
| Term loan payments | 0 | 11,429 |
| Payments on finance leases | 1,793 | 3,499 |
| Common stock repurchased and retired | 0 | 9,280 |
| Dividend payment | 0 | - |
| Proceeds from exercise of options | 0 | - |
| Taxes paid related to net share settlement of equity awards | 384 | 294 |
| Net cash used in financing activities | -31,177 | -10,957 |
| Effect of exchange rate changes | -159 | 2,498 |
| Net change in cash and restricted cash | 94,593 | -4,497 |
| Cash and cash equivalents at end of period | 163,374 | - |
Innovex International, Inc. (INVX)
Innovex International, Inc. (INVX)